Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-11-18 Opaleye Management Inc. 10% owner Purchase +1,000 $6.98 $7K 102,647
2021-11-17 Opaleye Management Inc. 10% owner Purchase +8,028 $6.98 $56K 2,472,500
2021-11-17 Opaleye Management Inc. 10% owner Purchase +1,090 $6.98 $8K 101,647
2021-11-04 Opaleye Management Inc. 10% owner Purchase +6,000 $6.50 $39K 2,464,472
2021-11-04 Opaleye Management Inc. 10% owner Purchase +557 $6.50 $4K 100,557
2021-06-10 Olivo Martin Sebastian Chief Medical Officer Purchase +4,959 $10.08 $50K 9,410
2021-06-10 Olivo Martin Sebastian Chief Medical Officer Purchase +4,934 $10.13 $50K 14,344
2021-06-09 Huang Jane Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2021-06-09 Huang Jane Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-09 Flannelly Barry P Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-09 Smith Cynthia Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-09 Levy Richard S Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-09 Solomon Michael Edward Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-09 SARGEN GREGORY Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-09 GARCEAU ROGER Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-09 BESHAR LUKE M Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-04-19 Olivo Martin Sebastian Chief Medical Officer Grant or award · Stock Option (Right to Buy) +120,000 120,000
2021-01-29 Smith Cynthia Director Grant or award · Stock Option (Right to Buy) +18,000 18,000
2021-01-29 Smith Cynthia Director Grant or award · Stock Option (Right to Buy) +3,750 21,750
2021-01-19 Davis Blaine Chief Financial Officer Grant or award · Stock Option (Right to Buy) +75,000 75,000

Page 12 of 17 · 335 trades